{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:07:28Z","timestamp":1768975648655,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Aim of this study was to analyze the efficacy and tolerability of simultaneous integrated boost volumetric modulated arc therapy (SIB-VMAT) associated with cisplatin-based chemotherapy in preoperative setting of patients with locally advanced cervical cancer (LACC). From June 2013 to September 2019, we analyzed patients with LACC who had undergone neoadjuvant chemoradiation (CRT). A radiation dose of 39.6\u2009Gy, 1.8\u2009Gy\/fraction was delivered to the pelvis plus a radiation dose to the primary tumor delivered with SIB-VMAT strategy for a total of 50.6Gy, 2.3Gy\/fraction in 25 fractions. Cisplatin-based chemotherapy was delivered combined with radiotherapy. Radical hysterectomy plus pelvic with or without aortic lymphadenectomy was performed within 7 to 8 weeks from CRT. One hundred forty-eight patients (median age: 49.5 years; FIGO stage IB2: 7, IIA: 8, IIB: 106, IIIA: 5; IIIB: 16; IVA: 5, IVB: 1; N0: 56, N1: 92) were analyzed. The treatment was well tolerated with good compliance: no grade 3\/4 gastrointestinal or genitourinary toxicity was reported; grade 3 neutropenia was described in five cases. Pathological complete response (pCR) was documented in 68 cases (46%) and 32 patients (21.6%) had microscopic residual disease. Pathological nodal involvement was observed in 23 patients (15.5%). At median follow-up of 59 months (range: 27-100), the 3-year local control was 78.5%, whereas the 3-year metastasis-free survival was 70.5%. The 3-year overall survival rate was 89.0%. Neoadjuvant CRT with SIB-VMAT followed by radical surgery results in a high rate of pathologically assessed complete response and a very encouraging local control rate, with acceptable toxicity.<\/jats:p>","DOI":"10.3389\/fonc.2022.883965","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T04:50:00Z","timestamp":1651726200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Neoadjuvant Chemoradiotherapy With Simultaneous Integrated Boost in Locally Advanced Cervical Cancer: Long Term Results of a Single-Center Experience"],"prefix":"10.3389","volume":"12","author":[{"given":"Alessia","family":"Nardangeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Campitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Reina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00f2","family":"Bizzarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO Staging for Carcinoma of the Vulva, Cervix, and Endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008285","article-title":"Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: Individual Patient Data Meta-Analysis","year":"2010","journal-title":"Cochrane Database System Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.179","article-title":"Neoadjuvant Chemotherapy and Radical Surgery Versus Exclusive Radiotherapy in Locally Advanced Squamous Cell Cervical Cancer: Results From the Italian Multicenter Randomized Study","volume":"20","author":"Benedetti-Panici","year":"2002","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.07.006","article-title":"Preoperative Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer: Safety, Outcome, and Prognostic Measures","volume":"107","author":"Ferrandina","year":"2007","journal-title":"Gynecol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.01.022","article-title":"Surgery After Concurrent Chemoradiotherapy and Brachytherapy for the Treatment of Advanced Cervical Cancer: Morbidity and Outcome: Results of a Multicenter Study of the GCCLCC (Groupe Des Chirurgiens De Centre De Lutte Contre Le Cancer)","volume":"102","author":"Classe","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.08.004","article-title":"Long-Term Analysis of Clinical Outcome and Complications in Locally Advanced Cervical Cancer Patients Administered Concomitant Chemoradiation Followed by Radical Surgery","volume":"119","author":"Ferrandina","year":"2010","journal-title":"Gynecol Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1634\/theoncologist.2011-0276","article-title":"Results of the GYNECO 02 Study, an FNCLCC Phase III Trial Comparing Hysterectomy With No Hysterectomy in Patients With a (Clinical and Radiological) Complete Response After Chemoradiation Therapy for Stage IB2 or II Cervical Cancer","volume":"17","author":"Morice","year":"2012","journal-title":"Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt142","article-title":"Brachytherapy Versus Radical Hysterectomy After External Beam Chemoradiation With Gemcitabine Plus Cisplatin: A Randomized, Phase III Study in IB2\u2013IIB Cervical Cancer Patients","volume":"24","author":"Cetina","year":"2013","journal-title":"Ann Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.05.011","article-title":"Radical Hysterectomy After Chemoradiation in FIGO Stage III Cervical Cancer Patients Versus Chemoradiation and Brachytherapy: Complications and 3-Years Survival","volume":"42","author":"Fanfani","year":"2016","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3471-y","article-title":"Completion Surgery After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Comprehensive Analysis of Pattern of Postoperative Complications","volume":"21","author":"Ferrandina","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.09.029","article-title":"Pathological Response on Surgical Samples is an Independent Prognostic Variable for Patients With Stage Ib2\u2013IIb Cervical Cancer Treated With Neoadjuvant Chemotherapy and Radical Hysterectomy: An Italian Multicenter Retrospective Study (CTF Study)","volume":"131","author":"Gadducci","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2016.05.003","article-title":"Hypofractionated Radiotherapy in Pancreatic Cancer: Lessons From the Past in the Era of Stereotactic Body Radiation Therapy","volume":"103","author":"De Bari","year":"2016","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2013.11.003","article-title":"Utilization of Intensity-Modulated Radiation Therapy and Image-Guided Radiation Therapy in Pancreatic Cancer: Is It Beneficial","volume":"24","author":"Reese","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1586\/era.09.16","article-title":"Role of Intensity-Modulated Radiation Therapy in Gastrointestinal Cancer","volume":"9","author":"Bockbrader","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.04.017","article-title":"Concomitant Boost Dose Escalation Plus Large-Field Preoperative Chemoradiation in Locally Advanced Carcinoma of the Uterine Cervix: Results of a Phase I Study (LARA-CC-1)","volume":"118","author":"Macchia","year":"2010","journal-title":"Gynecol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.03.008","article-title":"Concomitant Boost Plus Large-Field Preoperative Chemoradiation in Locally Advanced Uterine Cervix Carcinoma: Phase II Clinical Trial Final Results (LARA-CC-1)","volume":"125","author":"Macchia","year":"2012","journal-title":"Gynecol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150385","article-title":"Intensity-Modulated Extended-Field Chemoradiation Plus Simultaneous Integrated Boost in the Pre-Operative Treatment of Locally Advanced Cervical Cancer: A Dose-Escalation Study","volume":"88","author":"Macchia","year":"2015","journal-title":"Br J Radiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(08)70074-3","article-title":"Classification of Radical Hysterectomy","volume":"9","author":"Querleu","year":"2008","journal-title":"Lancet Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation From Incomplete Observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Koh","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, Radiation, and Adjuvant Hysterectomy Compared With Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic Radiation With Concurrent Chemotherapy Compared With Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer","volume":"340","author":"Morris","year":"1999","journal-title":"New Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer","volume":"340","author":"Rose","year":"1999","journal-title":"New Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.8324","article-title":"Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions","volume":"25","author":"Monk","year":"2007","journal-title":"JCO"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810715)48:1+<560::aid-cncr2820481320>3.0.co;2-t","article-title":"Prognostic Factors in Cervical Carcinoma: Implications in Staging and Management","author":"Rotman","year":"1981","journal-title":"Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0090-8258(84)90151-3","article-title":"Survival and Patterns of Recurrence in Cervical Cancer Metastatic to Periaortic Lymph Nodes (A Gynecologic Oncology Group Study)","volume":"19","author":"Berman","year":"1984","journal-title":"Gynecol Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.04.009","article-title":"Patterns of Regional Recurrence After Definitive Radiotherapy for Cervical Cancer","volume":"76","author":"Beadle","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.3802\/jgo.2018.29.e25","article-title":"Impact of Adjuvant Hysterectomy on Prognosis in Patients With Locally Advanced Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Meta-Analysis","volume":"29","author":"Shim","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.07.033","article-title":"Chemoradiation With Concomitant Boosts Followed by Radical Surgery in Locally Advanced Cervical Cancer: Long-Term Results of the ROMA-2 Prospective Phase 2 Study","volume":"90","author":"Ferrandina","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.3802\/jgo.2019.30.e41","article-title":"Preoperative Chemoradiation Followed by Hysterectomy for Cervical Cancer: Patterns of Care and Survival in a Large, Hospital Database","volume":"30","author":"Albert","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.064","article-title":"Severe Late Toxicities Following Concomitant Chemoradiotherapy Compared to Radiotherapy Alone in Cervical Cancer: An Inter-Era Analysis","volume":"84","author":"Gondi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2008.03.001","article-title":"Long-Term Survival and Late Toxicity After Chemoradiotherapy for Cervical Cancer \u2014 The Addenbrooke\u2019s Experience","volume":"20","author":"Tan","year":"2008","journal-title":"Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01","volume":"22","author":"Eifel","year":"2004","journal-title":"JCO"},{"key":"B36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/diagnostics11040631","article-title":"Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer","volume":"11","author":"Gui","year":"2021","journal-title":"Diagnostics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-018-0951-y","article-title":"Delta Radiomics for Rectal Cancer Response Prediction With Hybrid 0.35 T Magnetic Resonance-Guided Radiotherapy (MRgRT): A Hypothesis-Generating Study for an Innovative Personalized Medicine Approach","volume":"124","author":"Boldrini","year":"2019","journal-title":"Radiol Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/0300891620901752","article-title":"Low Tesla Magnetic Resonance Guided Radiotherapy for Locally Advanced Cervical Cancer: First Clinical Experience","volume":"106","author":"Boldrini","year":"2020","journal-title":"Tumori"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.883965\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T04:50:03Z","timestamp":1651726203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.883965\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":38,"alternative-id":["10.3389\/fonc.2022.883965"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.883965","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"article-number":"883965"}}